Europe Liquid Biopsy Market

Historic Data: 2016-2017   |   Base Year: 2018   |   Forecast Period: 2019-2027

Analysis by Product & Services (Equipment, Reagents & Kits and Services); Sample (Blood Based, Urine Based and Other samples); Circulating Biomarker (Circulating Tumor Cells (CTC), Exosomes and Free Nucleic Acid); Application (Noninvasive Prenatal Testing (NIPT), Oncology, Transplant Diagnostics and Other Applications); End User (Academic & Research Institutes, Hospitals, Reference Laboratories and Other End Users); and, Country

No. of Pages: 148
Report Code: TIPRE00013007
Category: Life Sciences
Europe Liquid Biopsy Market

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Data Triangulation and Validation

4. Europe Liquid Biopsy Market Landscape

4.1 Overview
4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. Europe Liquid Biopsy Market – Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints

6. Europe Liquid Biopsy Market Regional Analysis

6.2 Europe Liquid Biopsy Market Revenue 2016-2027 (US$ Million)
6.3 Europe Liquid Biopsy Market Forecast Analysis

7. Europe Liquid Biopsy Market Analysis – by Product & Services

7.1 Equipment
  • 7.1.1 Overview
  • 7.1.2 Equipment: Europe Liquid Biopsy Market – Revenue and Forecast, 2016-2027 (US$ Million)
7.2 Reagents & Kits and Services
  • 7.2.1 Overview
  • 7.2.2 Reagents & Kits and Services: Europe Liquid Biopsy Market – Revenue and Forecast, 2016-2027 (US$ Million)

8. Europe Liquid Biopsy Market Analysis – by Sample

8.1 Blood Based
  • 8.1.1 Overview
  • 8.1.2 Blood Based: Europe Liquid Biopsy Market – Revenue and Forecast, 2016-2027 (US$ Million)
8.2 Urine Based and Other samples
  • 8.2.1 Overview
  • 8.2.2 Urine Based and Other samples: Europe Liquid Biopsy Market – Revenue and Forecast, 2016-2027 (US$ Million)

9. Europe Liquid Biopsy Market Analysis – by Circulating Biomarker

9.1 Circulating Tumor Cells
  • 9.1.1 Overview
  • 9.1.2 Circulating Tumor Cells: Europe Liquid Biopsy Market – Revenue and Forecast, 2016-2027 (US$ Million)
9.2 Exosomes and Free Nucleic Acid
  • 9.2.1 Overview
  • 9.2.2 Exosomes and Free Nucleic Acid: Europe Liquid Biopsy Market – Revenue and Forecast, 2016-2027 (US$ Million)

10. Europe Liquid Biopsy Market Analysis – by Application

10.1 Noninvasive Prenatal Testing
  • 10.1.1 Overview
  • 10.1.2 Noninvasive Prenatal Testing: Europe Liquid Biopsy Market – Revenue and Forecast, 2016-2027 (US$ Million)
10.2 Oncology
  • 10.2.1 Overview
  • 10.2.2 Oncology: Europe Liquid Biopsy Market – Revenue and Forecast, 2016-2027 (US$ Million)
10.3 Transplant Diagnostics and Other Applications
  • 10.3.1 Overview
  • 10.3.2 Transplant Diagnostics and Other Applications: Europe Liquid Biopsy Market – Revenue and Forecast, 2016-2027 (US$ Million)

11. Europe Liquid Biopsy Market – Europe Analysis

11.1 Overview

11.2 Europe
  • 11.2.1 Europe Liquid Biopsy Market Breakdown, by Key Country, 2019 and 2027 (%)
  • 11.2.1.1 Europe Liquid Biopsy Market – Revenue and Forecast Analysis – by Country
  • 11.2.1.1 UK: Europe Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)
    • 11.2.1.1.1 UK: Europe Liquid Biopsy Market Breakdown, by Product & Services
    • 11.2.1.1.2 UK: Europe Liquid Biopsy Market Breakdown, by Sample
    • 11.2.1.1.3 UK: Europe Liquid Biopsy Market Breakdown, by Circulating Biomarker
    • 11.2.1.1.4 UK: Europe Liquid Biopsy Market Breakdown, by Application
  • 11.2.1.2 Germany: Europe Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)
    • 11.2.1.2.1 Germany: Europe Liquid Biopsy Market Breakdown, by Product & Services
    • 11.2.1.2.2 Germany: Europe Liquid Biopsy Market Breakdown, by Sample
    • 11.2.1.2.3 Germany: Europe Liquid Biopsy Market Breakdown, by Circulating Biomarker
    • 11.2.1.2.4 Germany: Europe Liquid Biopsy Market Breakdown, by Application
  • 11.2.1.3 France: Europe Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)
    • 11.2.1.3.1 France: Europe Liquid Biopsy Market Breakdown, by Product & Services
    • 11.2.1.3.2 France: Europe Liquid Biopsy Market Breakdown, by Sample
    • 11.2.1.3.3 France: Europe Liquid Biopsy Market Breakdown, by Circulating Biomarker
    • 11.2.1.3.4 France: Europe Liquid Biopsy Market Breakdown, by Application
  • 11.2.1.4 Russia: Europe Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)
    • 11.2.1.4.1 Russia: Europe Liquid Biopsy Market Breakdown, by Product & Services
    • 11.2.1.4.2 Russia: Europe Liquid Biopsy Market Breakdown, by Sample
    • 11.2.1.4.3 Russia: Europe Liquid Biopsy Market Breakdown, by Circulating Biomarker
    • 11.2.1.4.4 Russia: Europe Liquid Biopsy Market Breakdown, by Application
  • 11.2.1.5 Italy: Europe Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)
    • 11.2.1.5.1 Italy: Europe Liquid Biopsy Market Breakdown, by Product & Services
    • 11.2.1.5.2 Italy: Europe Liquid Biopsy Market Breakdown, by Sample
    • 11.2.1.5.3 Italy: Europe Liquid Biopsy Market Breakdown, by Circulating Biomarker
    • 11.2.1.5.4 Italy: Europe Liquid Biopsy Market Breakdown, by Application
  • 11.2.1.6 Rest of Europe: Europe Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)
    • 11.2.1.6.1 Rest of Europe: Europe Liquid Biopsy Market Breakdown, by Product & Services
    • 11.2.1.6.2 Rest of Europe: Europe Liquid Biopsy Market Breakdown, by Sample
    • 11.2.1.6.3 Rest of Europe: Europe Liquid Biopsy Market Breakdown, by Circulating Biomarker
    • 11.2.1.6.4 Rest of Europe: Europe Liquid Biopsy Market Breakdown, by Application

12. Competitive Landscape

12.1 Heat Map Analysis
12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments

14. Company Profiles

14.1 F. Hoffmann-la Roche ltd
  • 14.1.1 Key Facts
  • 14.1.2 Business Description
  • 14.1.3 Products and Services
  • 14.1.4 Financial Overview
  • 14.1.5 SWOT Analysis
  • 14.1.6 Key Developments
14.2 Inivata Ltd
  • 14.2.1 Key Facts
  • 14.2.2 Business Description
  • 14.2.3 Products and Services
  • 14.2.4 Financial Overview
  • 14.2.5 SWOT Analysis
  • 14.2.6 Key Developments
14.3 LungLife AI, Inc.
  • 14.3.1 Key Facts
  • 14.3.2 Business Description
  • 14.3.3 Products and Services
  • 14.3.4 Financial Overview
  • 14.3.5 SWOT Analysis
  • 14.3.6 Key Developments
14.4 Exosome Diagnostics
  • 14.4.1 Key Facts
  • 14.4.2 Business Description
  • 14.4.3 Products and Services
  • 14.4.4 Financial Overview
  • 14.4.5 SWOT Analysis
  • 14.4.6 Key Developments
14.5 MDxHealth
  • 14.5.1 Key Facts
  • 14.5.2 Business Description
  • 14.5.3 Products and Services
  • 14.5.4 Financial Overview
  • 14.5.5 SWOT Analysis
  • 14.5.6 Key Developments

15. Appendix

15.1 About Business Market Insights
15.2 List of Abbreviations

The List of Companies - Europe Liquid Biopsy Market

  • F. Hoffmann-la Roche ltd
  • Inivata Ltd
  • LungLife AI, Inc.
  • Exosome Diagnostics
  • MDxHealth
  • Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now
    Customization Form

    Please tell us your area of interest
    (Market Segments/ Regions and Countries/ Companies)